BRAF and colorectal carcinoma: The mutation status of the CRC samples was determined for KRAS and BRAF. Tissues were lysed and, in a robotized procedure, proteins were immobilized to the wall of thin capillaries using UV exposure, followed by incubation with primary and secondary antibodies and ECL-detection, as outlined schematically in Fig. 1a.